# A Study With GLPG1972 in Osteoarthritis Subjects

> **NCT03311009** · PHASE1 · COMPLETED · sponsor: **Lakefront Biotherapeutics NV** · enrollment: 30 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** GLPG1972 cohort 1
- **DRUG:** GLPG1972 cohort 2
- **DRUG:** GLPG1972 cohort 3
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03311009
- **Lead sponsor:** Lakefront Biotherapeutics NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-15
- **Primary completion:** 2017-10-25
- **Final completion:** 2017-10-25
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03311009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03311009, "A Study With GLPG1972 in Osteoarthritis Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03311009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*